AAI Development Services
With over 1000 employees worldwide, AAI Development Services is a leading contract development organisation.
A 65 bed Clinical Pharmacology unit in Neu-Ulm, Germany, conducts Phase I and Phase IIa studies in a wide range of volunteer and patient populations. Phase II to IV studies are conducted in Europe out of centres in Paris, Neu-Ulm and Arnhem, and complement the significant clinical capabilities of AAI’s US Clinical Division..
In addition to full service clinical capabilities, the centre in Neu-Ulm has one of the largest Bioanalytical capabilities in Europe (over 350 non-proprietary analytical methods) and also services requirements for GMP standard Product Development, Clinical Trial Manufacturing and Supply. www.aaipharma.com |